Check Capital Management's Chris Ballard reacts to the Google parent's results in an exclusive interview with TheStreet.

Shares slipped after mixed quarterly results, as investors weighed flat revenue, divestitures and uncertainty over how AI ...

The league is so important to the business of media companies that they are likely to have little choice but to agree to ...

From McKinsey & Company to Boston Consulting Group, AI has now become a factor in the case interview.

Alphabet shares fell despite an earnings beat as investors focused on a sharp increase in AI capital spending and broader ...

The Trump administration in November announced steep discounts for Novo’s blockbuster drugs Ozempic and Wegovy sold to ...

The Montreal point-of-sale software company delivered the latest in a string of earnings beats since founder Dax Dasilva returned to the chief executive role two years ago. Lightspeed generated US$312 ...

Subramaniam—FedEx's second-ever CEO, and a company lifer—now has to lead the Global 500 company without founder Fred Smith ...

Cao Renxian is one of China’s richest men in an industry the world can’t live without, yet almost no one outside the business ...

Paul Hudson has yet to solve a conundrum raised with him when he took charge of Sanofi in 2019: finding a successor to its hit drug Dupixent. The eczema and asthma treatment made up more than a third ...

Cao Renxian is one of China’s richest men in an industry the world can’t live without, yet almost no one outside the business knows his name.

ESPN analyst and ex-Lions QB Dan Orlovsky joined Dave Birkett to talk new Lions OC Drew Petzing, his interest in coaching and Super Bowl 60.